Data Analytics

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

A multi-billion dollar life science company needed pre diligence on a potential acquisition target